Neuronetics (STIM) Shareholder's Equity (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 13.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.27 Mn |
| Dec 31, 2025 | 26.24 Mn |
| Sep 30, 2025 | 27.36 Mn |
| Jun 30, 2025 | 31.51 Mn |
| Mar 31, 2025 | 39.53 Mn |
| Dec 31, 2024 | 31.80 Mn |
| Sep 30, 2024 | 9.38 Mn |
| Jun 30, 2024 | 19.39 Mn |
| Mar 31, 2024 | 27.66 Mn |
| Dec 31, 2023 | 34.19 Mn |
| Sep 30, 2023 | 37.94 Mn |
| Jun 30, 2023 | 45.48 Mn |
| Mar 31, 2023 | 48.35 Mn |
| Dec 31, 2022 | 57.06 Mn |
| Sep 30, 2022 | 62.99 Mn |
| Jun 30, 2022 | 68.42 Mn |
| Mar 31, 2022 | 76.60 Mn |
| Dec 31, 2021 | 85.18 Mn |
| Sep 30, 2021 | 91.08 Mn |
| Jun 30, 2021 | 97.17 Mn |
| Mar 31, 2021 | 101.97 Mn |
| Dec 31, 2020 | 25.49 Mn |
| Sep 30, 2020 | 27.48 Mn |
| Jun 30, 2020 | 29.44 Mn |
| Mar 31, 2020 | 36.51 Mn |
| Dec 31, 2019 | 47.85 Mn |
| Sep 30, 2019 | 54.33 Mn |
| Jun 30, 2019 | 59.82 Mn |
| Mar 31, 2019 | 65.42 Mn |
| Dec 31, 2018 | 71.04 Mn |
| Sep 30, 2018 | 76.35 Mn |
| Jun 30, 2018 | -205.27 Mn |
| Mar 31, 2018 | -197.97 Mn |
| Dec 31, 2017 | -192.65 Mn |
| Dec 31, 2016 | -177.12 Mn |